Celanese Corporation (CE) Income Statement

The revenue trend shows a persistent deceleration, with year-over-year growth rates remaining negative for eight consecutive quarters, ranging from -2.2% to -8.7%. The modest sequential rebound in 2026Q2 (from $2.3B to $2.8B) appears to be a seasonal uptick rather than a structural recovery, given the ongoing weakness in end markets like automotive and construction. Investors should monitor whether the Acetyl Chain's commodity pricing and Engineered Materials' volumes can stabilize, as the current trajectory suggests continued demand softness.

The gross margin trend shows a clear downward drift, with quarterly margins oscillating between 17.4% and 24.2% but generally trending lower. This compression likely reflects the narrowing methanol-to-gas spread, which undermines the Acetyl Chain's cost advantage, and higher inventory costs that have not been fully passed through. The company's ability to restore margins depends on feedstock cost normalization and successful pricing actions in a competitive environment, but the current data suggests structural margin pressure.

The operating leverage is highly volatile, with operating margins ranging from -59.3% to 10.0% over the past ten quarters. The massive losses in 2024Q4 and 2025Q3 appear to be driven by non-cash impairments or restructuring charges, as SG&A and R&D remained relatively stable. Excluding these anomalies, operating margins have hovered around 8-10%, suggesting that the underlying business has limited operating leverage, with cost reductions not scaling proportionally with revenue.

Management appears to be exercising cost discipline, with SG&A declining modestly despite revenue contraction, which has helped mitigate margin erosion. R&D spending has also been trimmed from $34M to $29M, suggesting a focus on cost containment. However, the absolute level of SG&A remains high relative to revenue, and further cuts may be necessary to offset the impact of lower volumes and pricing pressure.